Drugs & Targets FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma August 02, 2024Vol.50 No.31
Drugs & Targets FDA approves Shield blood test for colon cancer screening August 02, 2024Vol.50 No.31
Drugs & Targets FDA expands Jemperli + chemo approval to all adults with primary advanced or recurrent endometrial cancer August 02, 2024Vol.50 No.31
Drugs & Targets FDA grants Priority Review to Scemblix for newly-diagnosed Ph+ CML-CP August 02, 2024Vol.50 No.31
Drugs & Targets CHMP adopts positive opinion of Keytruda + Padcev for unresectable or metastatic urothelial carcinoma August 02, 2024Vol.50 No.31
Drugs & Targets CHMP adopts positive opinion of zolbetuximab for advanced gastric and gastroesophageal junction cancer August 02, 2024Vol.50 No.31
Drugs & Targets Expanded access program opens in the U.S. for TLX101-CDx, Telix’s investigational glioma imaging agent August 02, 2024Vol.50 No.31
Drugs & Targets Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities August 02, 2024Vol.50 No.31
